Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial
Biotech
Novartis channels Gargamel, terminating midphase SMURF1 trial
Novartis has terminated a phase 2 trial of its SMURF1 inhibitor in idiopathic pulmonary fibrosis.
Nick Paul Taylor
Oct 14, 2024 9:14am
New AI-powered program offers clinical trial insurance
Jul 24, 2024 10:00am
Insmed's shares double as lung disease med powers past phase 3
May 28, 2024 10:32am
Experts: To improve trial diversity, look to informed consent
May 8, 2024 2:45pm
Pfizer axes phase 3 sickle cell study, cites recruitment issues
Mar 26, 2024 5:31pm
NCI launches remote staff pilot to boost trial enrollment
Mar 5, 2024 4:00pm
